Pacer Advisors’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15K Buy
+531
New +$11.6K ﹤0.01% 2294
2024
Q3
Sell
-509
Closed -$7.91K 2586
2024
Q2
$7.91K Sell
509
-1,189
-70% -$14.4K ﹤0.01% 3586
2024
Q1
$18K Buy
+1,698
New +$17K ﹤0.01% 3462
2021
Q2
Sell
-1,154
Closed -$79K 1436
2021
Q1
$79K Sell
1,154
-758
-40% -$58.9K ﹤0.01% 1323
2020
Q4
$139K Sell
1,912
-582
-23% -$33.7K ﹤0.01% 1296
2020
Q3
$95K Buy
+2,494
New +$84.2K ﹤0.01% 1255
2018
Q4
Sell
-2,456
Closed -$71K 620
2018
Q3
$71K Buy
+2,456
New +$46K ﹤0.01% 1123

Other funds holding CDNA

Pacer Advisors's CDNA Position: Q2 2026 in Review

Pacer Advisors opened a new position in CareDx (CDNA) in Q2 2026: 531 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #2294 among its holdings. This is a return to the name: Pacer Advisors previously reported a position in CDNA as recently as Q2 2024.

Pacer Advisors first reported a position in CDNA in Q3 2018 and has held it in 7 quarters since. The position peaked at $139K in Q4 2020. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Pacer Advisors held 531 shares of CareDx worth $15K as of Q2 2026.
  • CareDx was a new Pacer Advisors position in Q2 2026.
  • CareDx made up ﹤0.01% of Pacer Advisors's portfolio in Q2 2026, its #2294 holding.
  • Pacer Advisors first reported a position in CareDx in Q3 2018 and has held it in 7 quarters since.
  • Pacer Advisors's CareDx position peaked at $139K in Q4 2020.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Pacer Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.